甲状腺自身免疫与中国甲状腺功能正常的辅助生殖技术女性胚胎质量或妊娠结局无关
本回顾性队列研究纳入中国一家三级转诊中心2016年4月至2022年2月首次完整接受体外受精或卵胞浆内单精子注射(IVF/ICSI)的甲状腺功能正常不孕女性,比较甲状腺自身免疫(TAI)阳性与阴性者的胚胎质量及临床结局。结果显示两组在优质卵裂期胚胎率、累积活产率(cLBR)及各项妊娠结局上均无显著差异。作者认为甲状腺功能正常女性中TAI与IVF/ICSI后的胚胎质量或cLBR无关,未来需大型研究确认。
要点
- 甲状腺功能正常不孕女性中,TAI阳性与阴性者的优质卵裂期胚胎率无显著差异。
- TAI阳性与阴性者的累积活产率(cLBR)无显著差异。
- 首次移植周期的临床妊娠率、早期流产率及活产率在两组间均无显著差异。
核心结论
- 本研究表明,甲状腺功能正常女性中TAI与IVF/ICSI后的胚胎质量或累积活产率无关。
- 作者指出未来需大型研究以确认这些发现。
研究设计与样本
- 回顾性队列研究,纳入2016年4月至2022年2月在一家三级转诊中心首次完整接受IVF/ICSI治疗的甲状腺功能正常不孕女性。
- TAI定义为血清甲状腺过氧化物酶浓度≥34 IU/mL或甲状腺球蛋白浓度≥115.0 IU/mL。
- 共纳入499例TAI阳性与2945例TAI阴性女性,平均(标准差)年龄分别为31.6(4.5)岁与30.9(4.4)岁(p=0.001)。
- 主要结局为优质卵裂期胚胎率与累积活产率(cLBR)。
主要发现
- TAI阴性组与TAI阳性组优质卵裂期胚胎率分别为11,139/22,553与1971/3820,调整率分别为52.8%与53.4%(p=0.66)。
- TAI阴性组与TAI阳性组cLBR分别为1917/2945与327/499,分别为53.4%与56.2%(p=0.31)。
- TAI阴性组与TAI阳性组取卵率分别为35,078/51,978与5853/8628,分别为69.1%与69.4%(p=0.65);受精率分别为23,067/34,197与3902/5728,分别为61.1%与62.2%(p=0.34);胚胎利用率分别为18,233/22,553与3156/3820,分别为80.2%与80.8%(p=0.61)。
- TAI阴性组与TAI阳性组囊胚形成率分别为7051/13,721与1192/2330,分别为48.5%与48.4%(p=0.97);优质囊胚率分别为4819/13,721与799/2330,分别为29.9%与29.4%(p=0.73)。
- 首次移植周期中,TAI阴性组与TAI阳性组临床妊娠率分别为1524/2808与248/482,分别为46.7%与44.6%(p=0.40);早期流产率分别为156/1524与23/248,分别为13.5%与11.5%(p=0.44);活产率分别为1338/2808与218/482,分别为37.4%与36.0%(p=0.55)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Studies have shown that thyroid autoimmunity (TAI) is associated with increased risks of adverse pregnancy outcomes. The aim of this study was to investigate the associations between TAI and embryo quality in euthyroid women undergoing in vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI). Methods: This retrospective cohort study included euthyroid infertile women with and without TAI (defined as a serum thyroperoxidase concentration ≥34 IU/mL or a thyroglobulin concentration ≥115.0 IU/mL) who underwent their first complete IVF/ICSI treatment cycles at a tertiary referral center between April 2016 and February 2022. Embryo quality measurements and clinical outcomes were compared between women with (TAI positive) and without TAI (TAI negative). The high-quality cleavage embryo rate and cumulative live birth rate (cLBR) were the primary outcomes. Results: A total of 499 TAI-positive and 2945 TAI-negative women were included in this study, and their mean (standard deviation) ages were 31.6 (4.5) and 30.9 (4.4) years, respectively (p = 0.001). The overall analysis showed no significant differences between TAI-negative and TAI-positive women in the high-quality cleavage embryo rate (n/N: 11,139/22,553 vs. 1971/3820; adjusted rate: 52.8% vs. 53.4%, p = 0.66) and cLBR (1917/2945 vs. 327/499; 53.4% vs. 56.2%, p = 0.31). Moreover, no significant differences were observed between TAI-negative and TAI-positive women in the rates of oocyte retrieval (35,078/51,978 vs. 5853/8628; 69.1% vs. 69.4%; p = 0.65), fertilization (23,067/34,197 vs. 3902/5728; 61.1% vs. 62.2%, p = 0.34), embryo utilization (18,233/22,553 vs. 3156/3820; 80.2% vs. 80.8%, p = 0.61), blastocyst formation (7051/13,721 vs. 1192/2330; 48.5% vs. 48.4%, p = 0.97), and high-quality blastocysts (4819/13,721 vs. 799/2330; 29.9% vs. 29.4%, p = 0.73). Furthermore, no significant differences were observed between TAI-negative and TAI-positive women in the clinical pregnancy rate (1524/2808 vs. 248/482; 46.7% vs. 44.6%, p = 0.40), early pregnancy loss rate (156/1524 vs. 23/248; 13.5% vs. 11.5%, p = 0.44), and LBR (1338/2808 vs. 218/482; 37.4% vs. 36.0%, p = 0.55) of the first transfer cycle. Conclusions: This study demonstrated that TAI in women was not associated with embryo quality or the cLBR following IVF/ICSI. Future large studies are warranted to confirm these findings.
引用
- Rao M, Zeng Z, Zhang Q, et al. Thyroid Autoimmunity Is Not Associated with Embryo Quality or Pregnancy Outcomes in Euthyroid Women Undergoing Assisted Reproductive Technology in China. Thyroid. 2023. PMID: 36571280. doi:10.1089/thy.2022.0184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。